Patents by Inventor Nadine Hall

Nadine Hall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of a cannabinoid and a chemotheraopeutic agent for the treatment of breast cancer
    Patent number: 11607423
    Abstract: The present invention in the field of cancer therapeutics is based on the finding (illustrated in FIG. 4) that when cannabinoids are administered to cancer cells after a chemotherapeutic agent has been administered, the combined treatment leads to lower cancer cell viability than administration of the chemotherapeutic agent alone. There is provided a pharmaceutical composition comprising a chemotherapeutic agent for use in the treatment of breast cancer, wherein said treatment comprises a first phase in which the chemotherapeutic agent is administered, and a subsequent second phase in which a cannabinoid is administered.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: March 21, 2023
    Assignee: Akos Biosciences, Inc.
    Inventors: Angus Dalgleish, Wai Liu, Nadine Hall
  • ADMINISTRATION REGIMES OF CANNABINOIDS IN COMBINATION WITH CHEMOTHERAPEUTICS AGAINST CANCER
    Publication number: 20220362168
    Abstract: The present invention in the field of cancer therapeutics is based on the finding that when cannabinoids are administered to cancer subjects after a chemotherapeutic agent has been administered, the combined treatment leads to increased survival prognosis, a reduction in disease progression, stabilisation of disease state and inhibition of tumour growth than administration of the chemotherapeutic agent alone. There is provided a pharmaceutical composition comprising a chemotherapeutic agent for use in the treatment of bladder, brain and spinal cord, colorectal, head and neck, lung, lymphoma, neuroendocrine, oesophageal, ovarian, pancreatic and prostate cancer, wherein said treatment comprises a first phase in which the chemotherapeutic agent is administered, and a subsequent second phase in which a cannabinoid is administered.
    Type: Application
    Filed: August 9, 2019
    Publication date: November 17, 2022
    Inventors: Wai Liu, Angus Dalgleish, Nadine Hall
  • COMBINATION OF A CANNABINOID AND A CHEMOTHERAOPEUTIC AGENT FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20210030779
    Abstract: The present invention in the field of cancer therapeutics is based on the finding (illustrated in FIG. 4) that when cannabinoids are administered to cancer cells after a chemotherapeutic agent has been administered, the combined treatment leads to lower cancer cell viability than administration of the chemotherapeutic agent alone. There is provided a pharmaceutical composition comprising a chemotherapeutic agent for use in the treatment of breast cancer, wherein said treatment comprises a first phase in which the chemotherapeutic agent is administered, and a subsequent second phase in which a cannabinoid is administered.
    Type: Application
    Filed: April 4, 2019
    Publication date: February 4, 2021
    Inventors: Angus Dalgleish, Wai Liu, Nadine Hall